Helix BioPharma (FRA:HBP0) Other Long Term Assets : €0.00 Mil (As of Apr. 2024)

View and export this data going back to . Start your Free Trial

What is Helix BioPharma Other Long Term Assets?

Helix BioPharma's other long-term assets for the quarter that ended in Apr. 2024 was €0.00 Mil.

Helix BioPharma's quarterly other long-term assets declined from Oct. 2023 (€0.00 Mil) to Jan. 2024 (€-0.00 Mil) but then increased from Jan. 2024 (€-0.00 Mil) to Apr. 2024 (€0.00 Mil).

Helix BioPharma's annual other long-term assets increased from Jul. 2021 (€0.00 Mil) to Jul. 2022 (€0.00 Mil) but then declined from Jul. 2022 (€0.00 Mil) to Jul. 2023 (€-0.00 Mil).

Helix BioPharma Other Long Term Assets Historical Data

The historical data trend for Helix BioPharma's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Helix BioPharma Other Long Term Assets Chart

Helix BioPharma Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Other Long Term Assets

Get a 7-Day Free Trial

Helix BioPharma Quarterly Data
	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24
Other Long Term Assets	Get a 7-Day Free Trial															-	-	-	-	-

Helix BioPharma Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Helix BioPharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Helix BioPharma Corp (FRA:HBP0) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

HBPCF:USA HBP:Canada

Address

401 Bay Street, Suite 2704, Toronto, ON, CAN, M5H 2Y

Website

https://www.helixbiopharma.com

Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidates are Tumor Defence Breaker L-DOS47, and, V-DOS47 among others.

Helix BioPharma Headlines

No Headlines